Cargando…

Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study

BACKGROUND: The aim of this study was to investigate the clinical characteristics and the risk factors associated with anti-tuberculosis (anti-TB) drug-induced liver injury (DILI). MATERIAL/METHODS: This retrospective study enrolled 140 hospitalized patients diagnosed with anti-TB DILI during Januar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hong, Wang, Yanbing, Zhang, Ting, Wang, Qi, Xie, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077058/ https://www.ncbi.nlm.nih.gov/pubmed/32145061 http://dx.doi.org/10.12659/MSM.920350

Ejemplares similares

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017)

Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
por: Moosa, Muhammed Shiraz, et al.
Publicado: (2022)

Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury
por: Wang, Shuting, et al.
Publicado: (2018)

The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies
por: Zheng, Jing, et al.
Publicado: (2020)

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
por: Shang, Penghui, et al.
Publicado: (2011)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

TANC1 methylation as a novel biomarker for the diagnosis of patients with anti-tuberculosis drug-induced liver injury
por: Wu, Dongxue, et al.
Publicado: (2021)

Mitochondrial DNA Variants in Patients with Liver Injury Due to Anti-Tuberculosis Drugs
por: Lee, Li-Na, et al.
Publicado: (2019)

An Investigation of the Risk Factors Associated With Anti-Tuberculosis Drug-Induced Liver Injury or Abnormal Liver Functioning in 757 Patients With Pulmonary Tuberculosis
por: Zhong, Tao, et al.
Publicado: (2021)

Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients
por: Mushiroda, Taisei, et al.
Publicado: (2016)

Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
por: Kim, Wan Soo, et al.
Publicado: (2016)

Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China
por: Li, Xu, et al.
Publicado: (2019)

The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
por: Zhang, Jingwei, et al.
Publicado: (2019)

Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort
por: Chen, Ru, et al.
Publicado: (2016)

Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019)

Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report
por: Aminy, Rusdi Zakki, et al.
Publicado: (2022)

1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
por: Acosta, Carina, et al.
Publicado: (2022)

RAD-140 Drug-Induced Liver Injury
por: Leung, Kenneth, et al.
Publicado: (2022)

Association of UGT2B7 polymorphisms with risk of induced liver injury by anti-tuberculosis drugs in Chinese Han
por: Chen, Guo, et al.
Publicado: (2017)

Dietary Intake of Vegetables and Cooking Oil Was Associated With Drug-Induced Liver Injury During Tuberculosis Treatment: A Preliminary Cohort Study
por: Wang, Jinyu, et al.
Publicado: (2021)

Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis
por: Cai, Yu, et al.
Publicado: (2012)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment
por: Du, Zhi Xiang, et al.
Publicado: (2022)

Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
por: Santos, Eliana Abreu, et al.
Publicado: (2019)

A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
por: Ji, Songjun, et al.
Publicado: (2023)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Hematological and liver toxicity of anti-tuberculosis drugs
por: Mirlohi, Maryam-Sadat, et al.
Publicado: (2016)

Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis
por: Saito, Zenya, et al.
Publicado: (2016)

Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti‐tuberculosis drug‐induced liver injury
por: Li, Biao, et al.
Publicado: (2022)

Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
por: Usui, Toru, et al.
Publicado: (2014)

CYP2S1 rs338599 polymorphism confers reduced risk to anti‐tuberculosis drug‐induced liver injury and may be a novel marker for its risk prediction
por: Wang, Liyuan, et al.
Publicado: (2022)

Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
por: Wu, Shanshan, et al.
Publicado: (2012)

Gut Microbiota Participates in Antithyroid Drug Induced Liver Injury Through the Lipopolysaccharide Related Signaling Pathway
por: Sun, Jiayu, et al.
Publicado: (2020)

Drug-induced Liver Injury Due to Lepidium meyenii (Maca) Medicinal Liquor
por: Xiao, An, et al.
Publicado: (2017)

Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury
por: Huang, Deliang, et al.
Publicado: (2023)

Systematic review and network meta-analysis of efficacy and safety of interventions for preventing anti-tuberculosis drug induced liver injury
por: Akkahadsee, Pattaraporn, et al.
Publicado: (2023)

Drug-Induced Liver Injury: Clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China
por: Liu, Yao, et al.
Publicado: (2020)

CSH guidelines for the diagnosis and treatment of drug-induced liver injury
por: Yu, Yue-cheng, et al.
Publicado: (2017)

Efficacy and safety of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mvmvv8623tugq1132eb75mj8ve